Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea, L-carnitine, and Magnesium in Beta Thalassemia Intermedia
NCT00809042Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2007
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine, magnesium chloride in beta-thalassemia intermedia, sponsored by Shiraz University of Medical Sciences. Started Jun 2007; status: completed.
02
Drugs
levocarnitinemagnesium chloride
03
Conditions
beta-thalassemia intermedia
Beyond the preview
Go deeper on NCT00809042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809042.